Vimarsana
Biggest News Aggregation in the World

Page 24 - Pfizer Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Ltd Today - Breaking & Trending Today

Pfizer Names Meenakshi Nevatia As Managing Director - Vimarsana News

Pfizer Names Meenakshi Nevatia As Managing Director

Drug maker Pfizer Ltd on Thursday said it has appointed Meenakshi Nevatia as managing director for a period of five years with effect from April 3, 2023.

Source: ndtv.com
Pfizer Ltd reports net profit of Rs. 150.66 crores in Q3 FY2023 - Vimarsana News

Pfizer Ltd reports net profit of Rs. 150.66 crores in Q3 FY2023

The Board of Directors of Pfizer Limited, at its meeting held today have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23 and 9MFY23.

Related Topics:
Pfizer LtdPfizer Limited
Chinese mRNA COVID-19 vaccine is approved for the first time in Indonesia - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader. - Vimarsana News

Chinese mRNA COVID-19 vaccine is approved for the first time in Indonesia - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

Indonesia said it has granted emergency use approval to an mRNA COVID-19 vaccine developed by a Chinese company, becoming the first country, ahead of even China, to do so.

How severe is Omicron compared to Delta? - Vimarsana News

How severe is Omicron compared to Delta?

Researchers assess the disease severity of hospitalized adult patients with COVID-19 through the use of three different health outcomes.

Novel oral chemotherapeutic holds potential for stomach cancer patients - Vimarsana News

Novel oral chemotherapeutic holds potential for stomach cancer patients

Carl Bjartmar of Ascelia Pharma explores the benefits of oral therapeutic administration over intravenous chemotherapy for stomach cancer patients, highlighting improvements in efficacy and ease of use.